Related Experiment Video
Updated: Jul 20, 2026
10:52
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
Published on: December 17, 2010
[Prenatal ACTH-depot therapy].
Marek Klimek1, Lech Kołodziejski, Dariusz Gołabek
1Klinika Ginekologii i Niepłodności, Katedry Ginekologii i Połoznictwa, Collegium Medicum, Uniwersytetu Jagiellońiskiego w Krakowie. gyninfo@mp.pl
Przeglad Lekarski
|September 14, 2006
Summary
Adrenocorticotropic hormone (ACTH)-depot therapy effectively treats threatened abortions and premature labor. This treatment improves pregnancy outcomes, leading to higher rates of full-term births and healthier infants compared to conservative methods.
Area of Science:
- Reproductive endocrinology
- Obstetrics
- Pharmacology
Context:
- Threatened abortion and premature labor pose significant risks to maternal and infant health.
- Established treatments have limitations and varying success rates.
- Adrenocorticotropic hormone (ACTH)-depot therapy, introduced in the 1960s, offers a therapeutic option.
Purpose:
- To evaluate the efficacy and safety of ACTH-depot therapy in managing neuroendocrinologically complicated pregnancies.
- To compare ACTH-depot therapy outcomes with conservative treatment approaches.
- To explore the role of oxytocinase levels in monitoring pregnancy progression during ACTH-depot treatment.
Summary:
- ACTH-depot therapy demonstrated high success rates (96% at-term pregnancies) compared to conservative methods (18.5%-37%).
- Oxytocinase levels can monitor pregnancy development in patients receiving ACTH-depot.
- The therapy is safe for mother and infant, with fewer side effects than corticosteroids and without protein catabolism issues.
Impact:
- ACTH-depot therapy normalizes preterm labor rates and reduces respiratory disorders in newborns.
- It offers a beneficial alternative to corticosteroid administration due to placental non-transfer and enhanced endogenous hormone production.
- Single-dose ACTH-depot therapy can resolve symptoms of threatened premature labor, potentially eliminating the need for tocolytic agents.
More Related Videos
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:37Hypothalamic-Pituitary Axis
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...